Author

Warren C. Fiskus

The University of Texas MD Anderson Cancer CenterORCID 0000-0002-7343-6214Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Kapil N. BhallaiD· 2 shared Alyssa C. BouskaiD· 1 shared Andreas RosenwaldiD· 1 shared Andrew J. GentlesiD· 1 shared Anna MalovannayaiD· 1 shared Antrix JainiD· 1 shared Ash A. AlizadehiD· 1 shared Branko CuglievaniD· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Kapil N. BhallaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyBloodPeer-reviewedMar 4, 2024

BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor

Warren C. Fiskus, Jessica C. Piel, Michael P. Collins…·Kapil N. Bhalla

This study shows that FHD-286, a BRG1/BRM inhibitor, reduces AML burden and improves survival when combined with Menin or BET inhibitors in xenograft models of AML with MLL1r or mtNPM1.

49 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsScience Translational MedicinePeer-reviewedJun 19, 2019

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in the activated B-cell subtype of diffuse large B-cell lymphoma

Neeraj Kumar Jain, Keenan T. Hartert, Saber Tadros…·Michael R. Green

The paper identifies TCF4 overexpression driven by 18q21.2 gains as a mechanism promoting IgM expression in ABC-like DLBCL and shows BET inhibitors can suppress it.

64 citationstop 2%

humanwhole-genome sequencing

𝕏 PostBluesky